Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination.

[1]  A. Turpie.  Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[2]  A. Spyropoulos.  Investigational treatments of venous thromboembolism , 2007, Expert opinion on investigational drugs.

[3]  J. Weitz,et al.  Beyond heparin and warfarin: the new generation of anticoagulants , 2007, Expert opinion on investigational drugs.

[4]  S. Schellong,et al.  New anticoagulants , 2007, Hämostaseologie.

[5]  M. Okada,et al.  Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands. , 2007, Bioorganic & medicinal chemistry.

[6]  E. Gjerstad,et al.  Potent 4-amino-5-azaindole factor VIIa inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[7]  D. Banner,et al.  Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity. , 2006, Bioorganic & medicinal chemistry.

[8]  B. Katz,et al.  Novel 5-azaindole factor VIIa inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[9]  B. Katz,et al.  Discovery of novel heterocyclic factor VIIa inhibitors. , 2006, Bioorganic & medicinal chemistry letters.

[10]  J. Janc,et al.  Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model. , 2006, Bioorganic & medicinal chemistry letters.

[11]  L. Weber,et al.  Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors. , 2005, Bioorganic & medicinal chemistry letters.

[12]  G. Poda,et al.  Structure-based design and synthesis of pyrazinones containing novel P1 'side pocket' moieties as inhibitors of TF/VIIa. , 2005, Bioorganic & medicinal chemistry letters.

[13]  T. Kayahara,et al.  Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library. , 2005, Bioorganic & medicinal chemistry.

[14]  G. Halliday,et al.  Tamarind Inhibits Solar-Simulated Ultraviolet Radiation-Induced Suppression of Recall Responses in Humans , 2005 .

[15]  S. Kadono,et al.  Structure of human factor VIIa/tissue factor in complex with a peptide-mimetic inhibitor: high selectivity against thrombin by introducing two charged groups in P2 and P4. , 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

[16]  Tsukasa Suzuki,et al.  Novel interactions of large P3 moiety and small P4 moiety in the binding of the peptide mimetic factor VIIa inhibitor. , 2005, Biochemical and biophysical research communications.

[17]  S. Kadono,et al.  Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor. , 2004, Biochemical and biophysical research communications.

[18]  T. Girard,et al.  Pharmacological Intervention at Disparate Sites in the Coagulation Cascade: Comparison of Anti-thrombotic Efficacy vs. Bleeding Propensity in a Rat Model of Acute Arterial Thrombosis , 2002, Journal of Thrombosis and Thrombolysis.

[19]  M. S. South,et al.  Pharmacological Interruption of Acute Thrombus Formation with Minimal Hemorrhagic Complications by a Small Molecule Tissue Factor/Factor VIIa Inhibitor: Comparison to Factor Xa and Thrombin Inhibition in a Nonhuman Primate Thrombosis Model , 2003, Journal of Pharmacology and Experimental Therapeutics.

[20]  D. Kirchhofer,et al.  Inhibition of Arterial Thrombosis by a Soluble Tissue Factor Mutant and Active Site-blocked Factors IXa and Xa in the Guinea Pig , 2001, Thrombosis and Haemostasis.

[21]  V. Fuster,et al.  Redefining medical treatment in the management of unstable angina. , 2011, The American journal of medicine.

[22]  J. Willerson,et al.  Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor. , 2000, Circulation.

[23]  K. Harlos,et al.  Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla). , 1999, Journal of structural biology.

[24]  A M Brzozowski,et al.  Structure of human factor VIIa and its implications for the triggering of blood coagulation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B Honig,et al.  On the calculation of binding free energies using continuum methods: Application to MHC class I protein‐peptide interactions , 1997, Protein science : a publication of the Protein Society.

[26]  R. Kelley,et al.  A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent. , 1997, Blood.

[27]  David W. Banner,et al.  The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.

[28]  B. Tidor,et al.  Do salt bridges stabilize proteins? A continuum electrostatic analysis , 1994, Protein science : a publication of the Protein Society.

[29]  S. Katakura,et al.  A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin. , 1993, Biochemical and biophysical research communications.

[30]  D. Turk,et al.  The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships , 1992, Protein science : a publication of the Protein Society.

[31]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[32]  R. Huber,et al.  The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989, The EMBO journal.

[33]  R. Kikumoto,et al.  Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl++ +) sulfonyl]-l-arginyl)]-2-piperidinecarboxylic acid. , 1984, Biochemistry.